Showing all 7 results
Co -Trimoxazole Tablets Tablet
FreeCo- Trimoxazole Tablets IP
Trimethoprime & Sulphamethoxazole Tablets IP
Each Uncoated tablet contains :
Trimethoprime IP 20 mg
Sulphamethoxazole IP 100 mgTrimethoprim & sulphamethoxazole tablets IP Co -trimoxazole Tablets IP
Each film coated tablets : Excipients q.s
Trimethoprim IP 80 mg
Sulphamethoxazole IP 400 mgTrimethoprim & sulphamethoxazole tablets IP
Each film coated tablets :
Trimethoprim IP 160 mg
Sulphamethoxazole IP 800 mgCo – Trimoxazole Tablets BP
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated Tablet contains :
Trimethoprim BP 80 mg
Sulfamethoxazole BP 400 mgTACOT – DS
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated tablet contains :
Trimethoprim BP 160 mg
Sulphamethoxazole BP 800 mgUsage: – Traveler’s diarrhea
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Levofloxacin Tablets
FreeProduct Composition & Available Portfolio
We manufacture Levofloxacin across the complete, internationally standardized therapeutic spectrum to accommodate customized tissue-saturation requirements and specific treatment durations.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 250 mg Oral Solid Film-Coated Tablet Uncomplicated Infections: For standard low-dose management of uncomplicated urinary tract infections (UTIs) and acute bacterial sinusitis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 500 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard for community-acquired pneumonia (CAP), skin structures, and acute pyelonephritis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 750 mg Oral High-Potency Solid Tablet Intensive High-Dose Short-Course: Calibrated for nosocomial pneumonia, complicated skin infections, and advanced multi-drug resistant (MDR) regimens. Metronidazole Tablet
FreeProduct Composition & Available Strengths
We supply Metronidazole in standard, internationally recognized strengths optimized for adult and pediatric treatment regimens.
Active Ingredient Available Strengths Common Dosage Matrix Primary Clinical Target Metronidazole BP / IP / USP 200 mg Film-Coated / Uncoated Oral Tablet Pediatric & Low-Dose Titration: For delicate adjustments in mild amoebic dysentery or combination protocols. Metronidazole BP / IP / USP 400 mg Film-Coated / Uncoated Oral Tablet Standard Generic Backbone: Standard twice or thrice-daily dosing for dental abscesses and Giardiasis. Metronidazole BP / IP / USP 500 mg High-Potency Oral Tablet Institutional Target: High-volume strength preferred for anaerobic surgical prophylaxis and severe trichomoniasis. Norfloxacin Tablet
FreeProduct Composition & Strength
We supply Norfloxacin in the globally standardized therapeutic strength optimized for adult twice-daily dosage regimens.
Active Ingredient Strength (per Tablet) Primary Microbiological Function Norfloxacin USP / BP / IP 400 mg The DNA Gyrase Blocker: Eradicates susceptible urinary and gastrointestinal pathogens. Excipients Pharma Grade The Core Matrix: High-performance binders optimized for rapid tablet dissolution. Ofloxacin Tablets
FreeOfloxacin Tablets 200 mg
Each Filmcoated tablet contains :
Ofloxacin IP 200 mg
Excipients q.sYALLEY FLOX
Ofloxacin Tablets 200mg Each Film coated tablet contains :
Ofloxacin BP 200 mg
Excipients q.sOfnis -200
Ofloxacin Tablets
Each Filmcoated tablet contains :
Ofloxacin BP 200 mgUsage: – Treat bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Roxithromycin Tablets
FreeRoxiron-150
(Roxithromycin tablets 150 mg)
Each Film coated tablets contains:
Roxithromycin BP 150 mgUsage: – treats bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Sulphadiazine Tablets
FreeSulphadiazine Tablets IP
Each Uncoated Tablets Contains:
Sulphadiazine IP 500 mgUsage: – urinary tract infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
